Carnegie Capital Asset Management LLC increased its equity stake in Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get a rating) by 4.0% in the first quarter, according to its latest filing with the Securities and Exchange Commission. The fund held 19,212 shares of the drugstore operator after acquiring an additional 737 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $860,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also bought and sold shares of WBA. Rise Advisors LLC bought a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $27,000. Outfitter Financial LLC bought a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $31,000. City State Bank bought a new position in Walgreens Boots Alliance during the fourth quarter worth about $30,000. Iron Horse Wealth Management LLC increased its stake in Walgreens Boots Alliance by 56.0% during the first quarter. Iron Horse Wealth Management LLC now owns 635 shares of the drugstore operator worth $28,000 after purchasing an additional 228 shares during the period. Finally, West Bancorporation Inc. purchased a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors hold 57.02% of the company’s shares.
In other news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the company in a trade on Wednesday, May 11. The shares were sold at an average price of $150.00, for a total value of $900,000,000.00. Following the completion of the transaction, the insider now owns 52,854,867 shares of the company, valued at approximately $7,928,230,050. The sale was disclosed in an SEC filing, available at this link. Company insiders own 17.40% of the company’s shares.
NASDAQ WBA opened at $40.89 on Friday. The company has a quick ratio of 0.35, a current ratio of 0.74 and a debt ratio of 0.36. Walgreens Boots Alliance, Inc. has a 52 week low of $39.14 and a 52 week high of $55.00. The stock has a market capitalization of $35.32 billion, a PE ratio of 5.64, a growth price-earnings ratio of 1.59 and a beta of 0.55. The company has a 50-day moving average of $42.92 and a two-hundred-day moving average of $46.80.
Walgreens Boot Alliance (NASDAQ: WBA – Get a rating) last released its quarterly results on Thursday, March 31. The drugstore operator reported EPS of $1.59 for the quarter, beating the consensus estimate of $1.39 by $0.20. Walgreens Boots Alliance achieved a net margin of 4.62% and a return on equity of 19.15%. The company posted revenue of $33.76 billion in the quarter, compared to $33.33 billion expected by analysts. In the same quarter a year earlier, the company posted EPS of $1.40. The company’s revenue increased 3.0% year over year. On average, equity research analysts expect Walgreens Boots Alliance, Inc. to post earnings per share of 5.06 for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, June 10. Shareholders of record on Friday, May 20 received a dividend of $0.4775. This represents an annualized dividend of $1.91 and a dividend yield of 4.67%. The ex-dividend date was Thursday, May 19. Walgreens Boots Alliance’s payout ratio is 26.34%.
A number of equity research analysts have recently released WBA stock reports. Robert W. Baird downgraded shares of Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and reduced his price target for the company from $70.00 to $51.00 in a rating of research from Friday April 1st. Royal Bank of Canada cut its price target on Walgreens Boots Alliance shares from $52.00 to $46.00 and set an “industry performance” rating on the stock in a Friday research note April 1st. StockNews.com moved Walgreens Boots Alliance shares from a “hold” rating to a “buy” rating in a research note on Saturday, June 11. TheStreet downgraded shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a Monday, May 2 research note. Finally, UBS Group reduced its price target on Walgreens Boots Alliance shares from $52.00 to $49.00 and set a “neutral” rating on the stock in a Tuesday, April 5 research note. One analyst has assigned the stock a sell rating, nine have issued a hold rating and one has assigned the company’s stock a buy rating. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $49.77.
About Walgreens Boots Alliance (Get a rating)
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail business. It operates through two segments, United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumer and general merchandise through its pharmacies Retail.
Get news and reviews for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s free daily email newsletter.